한국어
Home › By date

Key filings, August 7, 2026

565 filings · 12 highlights
← August 6, 2026August 10, 2026 →
EarningsSwung to profitAlteogenKOSDAQ
Operating profit
₩34.2B
Same quarter last year
-₩426M

Operating profit: swung to profit (-₩426M → ₩34.2B). Revenue ₩68.9B, up 269.5% YoY.

Q2 2026 · Separate
Company filings →Original (Korean) ↗

Supply contracts 18

8/7AmendedBHIWorth 66.4% of last year's revenue, over about 51 months.₩244B
8/7AmendedFaduWorth 47% of last year's revenue, over about 6 months.₩20.4B
8/7AmendedSoosan IndustriesWorth 27.1% of last year's revenue, over about 41 months.₩82.4B
8/7AmendedSC EngineeringWorth 21.9% of last year's revenue, over about 19 months.₩37.7B
8/7AmendedGeumhwa PSCWorth 19.9% of last year's revenue, over about 25 months.₩67.3B
8/7AmendedSeojin SystemWorth 15.3% of last year's revenue, over about 17 months.₩185B
8/7AmendedHDC HoldingsWorth 13.6% of last year's revenue.₩457B
8/7AmendedIpark Hyundai Development CompanyWorth 13.6% of last year's revenue.₩457B
8/7MobiisWorth 8.2% of last year's revenue, over about 9 months.₩415.9M
8/7PharmicellWorth 6.9% of last year's revenue, over about 3 months.₩7.9B
8/7SensorviewWorth 5.6% of last year's revenue, over about 53 months.₩1.1B
8/7AmendedIS DongseoWorth 5.4% of last year's revenue, over about 45 months.₩87.1B
8/7AmendedDaewoo Engineering & ConstructionWorth 4.3% of last year's revenue.₩374B
8/7AmendedSamsung C&TWorth 3.4% of last year's revenue, over about 58 months.₩1.48T
8/7HDC HoldingsWorth 3.4% of last year's revenue, over about 84 months.₩140B
8/7Ipark Hyundai Development CompanyWorth 3.4% of last year's revenue, over about 84 months.₩140B
8/7GS Engineering & ConstructionWorth 3.3% of last year's revenue.₩408B
8/7AmendedKC CottrellWorth 1.7% of last year's revenue, over about 10 months.₩7.4B

Preliminary earnings 58

8/7Swung to profitLotte ChemicalOperating profit: swung to profit (-₩250B → ₩110B). Revenue ₩5.69T, up 39.2% YoY.₩110B
8/7Swung to profitSimmtech HoldingsOperating profit: swung to profit (-₩3.7B → ₩57.6B). Revenue ₩558B, up 51.6% YoY.₩57.6B
8/7Swung to profitAlteogenOperating profit: swung to profit (-₩426M → ₩34.2B). Revenue ₩68.9B, up 269.5% YoY.₩34.2B
8/7Swung to lossDevsistersOperating profit: swung to loss (₩10.1B → -₩16B). Revenue ₩52.7B, down 42.7% YoY.-₩16B
8/7Swung to lossAVAOperating profit: swung to loss (₩20.1B → -₩12.7B). Revenue ₩12B, down 92.5% YoY.-₩12.7B
8/7Swung to profitKEPCO Engineering & Construction CompanyOperating profit: swung to profit (-₩511M → ₩3B). Revenue ₩103B, down 2.7% YoY.₩3B
8/7SeegeneOperating profit ₩21.6B, up 586.3% YoY. Revenue ₩136B, up 19.2% YoY.₩21.6B
8/7CJ CGVOperating profit ₩11.5B, up 568% YoY. Revenue ₩594B, up 20.8% YoY.₩11.5B
8/7Kumho Petro ChemicalOperating profit ₩339B, up 419.7% YoY. Revenue ₩2.27T, up 27.9% YoY.₩339B
8/7Advanced Process SystemsOperating profit ₩9.6B, up 254.2% YoY. Revenue ₩163B, up 47.7% YoY.₩9.6B
8/7Cosmax NBTOperating profit ₩8.5B, up 236.2% YoY. Revenue ₩102B, up 35.2% YoY.₩8.5B
8/7Advanced Nano ProductsOperating profit ₩5.3B, up 189.3% YoY. Revenue ₩36.5B, up 24.5% YoY.₩5.3B
8/7KortekOperating profit ₩16B, up 139.9% YoY. Revenue ₩130B, up 37.3% YoY.₩16B
8/7Lotte ShoppingOperating profit ₩89.9B, up 121.2% YoY. Revenue ₩3.49T, up 4% YoY.₩89.9B
8/7Kolon IndustriesOperating profit ₩98.7B, up 118% YoY. Revenue ₩1.36T, up 7.8% YoY.₩98.7B
8/7Lotte WellfoodOperating profit ₩64.7B, up 88.5% YoY. Revenue ₩1.16T, up 8.6% YoY.₩64.7B
8/7McnexOperating profit ₩2.2B, down 86.5% YoY. Revenue ₩295B, down 9.7% YoY.₩2.2B
8/7KoreaGasOperating profit ₩675B, up 66.9% YoY. Revenue ₩7.51T, down 1.6% YoY.₩675B
8/7TKG HuchemsOperating profit ₩32.8B, up 49.2% YoY. Revenue ₩397B, up 36.9% YoY.₩32.8B
8/7Hyungkuk F&BOperating profit ₩1.4B, down 49.2% YoY. Revenue ₩26.1B, up 2.9% YoY.₩1.4B
8/7DBOperating profit ₩12.9B, up 45.4% YoY. Revenue ₩230B, up 53.2% YoY.₩12.9B
8/7CS WindOperating profit ₩86B, up 45.2% YoY. Revenue ₩686B, up 5.6% YoY.₩86B
8/7NeopharmOperating profit ₩9.8B, up 39.6% YoY. Revenue ₩43.6B, up 36.2% YoY.₩9.8B
8/7Tokai Carbon KoreaOperating profit ₩26.9B, up 37.7% YoY. Revenue ₩94.9B, up 30.5% YoY.₩26.9B
8/7Sanil ElectricOperating profit ₩62.2B, up 34.3% YoY. Revenue ₩164B, up 28% YoY.₩62.2B
8/7Sanil ElectricOperating profit ₩62B, up 34.3% YoY. Revenue ₩164B, up 28% YoY.₩62B
8/7YG EntertainmentOperating profit ₩11B, up 31.2% YoY. Revenue ₩128B, up 27.2% YoY.₩11B
8/7WONIK MaterialsOperating profit ₩14.6B, up 28.9% YoY. Revenue ₩92.3B, up 23.1% YoY.₩14.6B
8/7Cell Biotech CO Operating profit ₩1.6B, up 28% YoY. Revenue ₩15.8B, up 32.8% YoY.₩1.6B
8/7VictekOperating profit ₩624M, down 27.5% YoY. Revenue ₩22.6B, up 54% YoY.₩624M
8/7GS RetailOperating profit ₩109B, up 27.5% YoY. Revenue ₩3.18T, up 6.7% YoY.₩109B
8/7DoznOperating profit ₩4.2B, up 27.2% YoY. Revenue ₩15B, up 2.7% YoY.₩4.2B
8/7IncrossOperating profit ₩2.8B, up 26.1% YoY. Revenue ₩11.7B, up 13.1% YoY.₩2.8B
8/7ktcsOperating profit ₩9.7B, down 24.7% YoY. Revenue ₩238B, down 3.9% YoY.₩9.7B
8/7PharmaResearchOperating profit ₩66.5B, up 19% YoY. Revenue ₩179B, up 27.1% YoY.₩66.5B
8/7DoznOperating profit ₩3.6B, up 17.1% YoY. Revenue ₩15B, up 2.7% YoY.₩3.6B
8/7ParadiseOperating profit ₩35.5B, down 17% YoY. Revenue ₩318B, up 11.8% YoY.₩35.5B
8/7Kyochon Food&beverageOperating profit ₩7.8B, down 15.7% YoY. Revenue ₩132B, up 4.9% YoY.₩7.8B
8/7Hyundai G.f. HoldingsOperating profit ₩85.3B, up 15.6% YoY. Revenue ₩2.06T, up 2.8% YoY.₩85.3B
8/7IncrossOperating profit ₩2.6B, up 14.2% YoY. Revenue ₩10B, up 10.2% YoY.₩2.6B
All preliminary earnings →

Insider trades 90

8/7BuyAhnlab10%+ shareholder bought 28,000 sh on the market at an average ₩51,963, Jul 31.₩1.5B
8/7BuyAgabang&companyAn insider bought 240,468 sh on the market at an average ₩4,763, Aug 3–7.₩1.1B
8/7BuyINNOX Advanced Materials10%+ shareholder bought 53,123 sh on the market at an average ₩17,777, Jul 31–Aug 3.₩944.4M
8/7BuyKG Chemical10%+ shareholder bought 228,978 sh on the market at an average ₩3,950, Jul 31–Aug 7.₩904.4M
8/7SaleSamsung Electronics Co,President sold 2,300 sh on the market at an average ₩248,000, Aug 4.₩570.4M
8/7SaleSamsung Electronics Co,President sold 2,000 sh on the market at an average ₩260,000, Aug 4.₩520M
8/7SaleSamsung Electronics Co,President sold 1,400 sh on the market at an average ₩243,714, Aug 4–5.₩341.2M
8/7BuyMIRAE ASSET Life Insurance10%+ shareholder bought 22,539 sh on the market at an average ₩13,969, Jul 31–Aug 3.₩314.9M
8/7BuyKumyang Green PowerCEO bought 40,200 sh on the market at an average ₩7,452, Aug 4–10.₩299.6M
8/7BuyEyesvisionAn insider bought 161,689 sh on the market at an average ₩967, Aug 4–6.₩156.4M
8/7BuySeoulAuctionCo.Ltd..Director bought 33,001 sh on the market at an average ₩4,709, Jul 31–Aug 6.₩155.4M
8/7BuyUnickCEO bought 40,000 sh on the market at an average ₩3,722, Aug 4.₩148.9M
8/7BuyJoyCity10%+ shareholder bought 96,743 sh on the market at an average ₩1,121, Aug 3–7.₩108.4M
8/7BuyHankook SteelCEO bought 44,855 sh on the market at an average ₩2,318, Aug 5–7.₩104M
8/7SaleEugeneTechnologyExecutive sold 1,000 sh on the market at an average ₩101,500, Jul 31.₩101.5M
8/7BuyPlaywith Korea10%+ shareholder bought 40,681 sh on the market at an average ₩2,428, Aug 3–10.₩98.8M
8/7SaleHanjoo ART10%+ shareholder sold 25,769 sh on the market at an average ₩3,811, Aug 4–6.₩98.2M
8/7BuyDx & VxDirector bought 39,296 sh on the market at an average ₩2,338, Aug 4–7.₩91.9M
8/7BuyKSS Line10%+ shareholder bought 8,596 sh on the market at an average ₩10,004, Aug 4–5.₩86M
8/7BuyModa-InnoChipsCEO bought 51,600 sh on the market at an average ₩1,611, Aug 4–7.₩83.1M
8/7BuyGC BiopharmaExecutive bought 500 sh on the market at an average ₩117,800, Jul 31.₩58.9M
8/7SaleClobotExecutive sold 23,123 sh on the market at an average ₩2,311, Aug 5–6.₩53.4M
8/7BuyIvisionworksCEO bought 67,605 sh on the market at an average ₩683, Aug 3.₩46.1M
8/7BuyJoyworks&President bought 48,000 sh on the market at an average ₩938, Aug 4–7.₩45M
8/7SaleNaverAn insider sold 200 sh on the market at an average ₩210,001, Jul 31.₩42M
8/7BuyCreverChairman bought 4,732 sh on the market at an average ₩8,319, Jul 31–Aug 6.₩39.4M
8/7SaleClobotExecutive sold 14,756 sh on the market at an average ₩2,256, Aug 4–5.₩33.3M
8/7BuyAirraneCEO bought 10,000 sh on the market at an average ₩2,999, Aug 5.₩30M
8/7BuyWelcron CompanyPresident bought 31,669 sh on the market at an average ₩946, Jul 31–Aug 5.₩30M
8/7BuyDentisCEO bought 11,224 sh on the market at an average ₩2,470, Aug 3–6.₩27.7M
8/7BuyDaehanPharmaceuticalChairman bought 836 sh on the market at an average ₩25,319, Jul 31.₩21.2M
8/7SaleClobotExecutive sold 9,448 sh on the market at an average ₩2,214, Aug 5.₩20.9M
8/7SaleClobotExecutive sold 9,072 sh on the market at an average ₩2,212, Aug 4–6.₩20.1M
8/7BuyYoungWoo DSPDirector bought 19,904 sh on the market at an average ₩930, Aug 3–4.₩18.5M
8/7BuyHugelDirector bought 73 sh on the market at an average ₩226,500, Jul 16–Aug 3.₩16.5M
8/7BuyYoungWoo DSPDirector bought 13,900 sh on the market at an average ₩944, Aug 3–5.₩13.1M
8/7BuySun&lExecutive bought 4,500 sh on the market at an average ₩2,253, Aug 7.₩10.1M
8/7BuyMetalabsDirector bought 9,240 sh on the market at an average ₩1,070, Aug 4–7.₩9.9M
8/7BuySC EngineeringDirector bought 10,000 sh on the market at an average ₩979, Aug 6.₩9.8M
8/7SaleSamsung Electronics Co,Executive sold 50 sh on the market at an average ₩194,800, Jul 31.₩9.7M
All insider trades →

5% holders 82

8/7New 5%SangboA major holder's stake rose from 0.00% to 16.99% (share lending).16.99%
8/7HanWool & JejuA major holder's stake fell from 47.97% to 24.24% (share consolidation/split).24.24%
8/7AmendedNew 5%Daeho ALA major holder's stake rose from 0.00% to 9.32% (new report).9.32%
8/7AmendedNew 5%CMG PharmaceuticalA major holder's stake rose from 0.00% to 9.20% (conversion/exercise).9.20%
8/7New 5%Korea Arlico PharmA major holder's stake rose from 0.00% to 7.41% (conversion/exercise).7.41%
8/7New 5%Hanchang PaperA major holder's stake rose from 0.00% to 6.09% (conversion/exercise).6.09%
8/7New 5%Shinsung E&GA major holder's stake rose from 0.00% to 5.14% (new report).5.14%
8/7New 5%DaejooElectronicMaterialsA major holder's stake rose from 0.00% to 5.04% (new report).5.04%
8/7Below 5%SangboA major holder's stake fell from 16.99% to 2.18% (share lending).2.18%
8/7Below 5%OSPA major holder's stake fell from 14.00% to 0.00% (off-market sale).0.00%
8/7FantagioA major holder's stake rose from 27.32% to 40.87% (open-market buy).40.87%
8/7New 5%Global Tax FreeA major holder's stake rose from 4.87% to 5.83%.5.83%
8/7New 5%ENF TechnologyA major holder's stake rose from 4.89% to 5.39%.5.39%
8/7New 5%Park SystemsA major holder's stake rose from 4.87% to 5.01%.5.01%
8/7New 5%AlteogenBlackRock's stake rose from 4.98% to 5.03%.5.03%
8/7AptnA major holder's stake fell from 21.38% to 12.20% (conversion/exercise).12.20%
8/7AribiolabA major holder's stake rose from 14.67% to 20.69% (related-party change).20.69%
8/7Korea Plasma Technology UA major holder's stake rose from 56.23% to 61.88%.61.88%
8/7Nice Information & TelecommunicationA major holder's stake rose from 44.10% to 48.47% (share consolidation/split).48.47%
8/7DYDA major holder's stake rose from 31.56% to 35.79% (rights offering).35.79%
8/7CnplusA major holder's stake rose from 28.98% to 32.55% (conversion/exercise).32.55%
8/7SupremaA major holder's stake rose from 5.05% to 8.00%.8.00%
8/7Kbio LabsA major holder's stake rose from 35.26% to 38.05% (rights offering).38.05%
8/7Below 5%PoledA major holder's stake fell from 5.92% to 3.34%.3.34%
8/7GaonchipsA major holder's stake fell from 46.87% to 44.71% (stock option).44.71%
8/7Sun&lA major holder's stake rose from 46.87% to 48.96% (related-party change).48.96%
8/7Mirae Asset SecuritiesA major holder's stake rose from 33.23% to 35.17% (related-party change).35.17%
8/7AprogenA major holder's stake rose from 14.91% to 16.55% (conversion/exercise).16.55%
8/7JB Financial GroupA major holder's stake rose from 6.38% to 7.99%.7.99%
8/7Hanjoo ARTA major holder's stake fell from 17.70% to 16.20% (open-market sale).16.20%
8/7XperixA major holder's stake fell from 21.48% to 20.04%.20.04%
8/7Samjin LND CompanyA major holder's stake rose from 23.31% to 24.64%.24.64%
8/7Hankook SteelA major holder's stake rose from 56.98% to 58.22%.58.22%
8/7ClassysA major holder's stake rose from 5.05% to 6.16%.6.16%
8/7Hansung CleantechA major holder's stake fell from 43.75% to 42.71% (conversion/exercise).42.71%
8/7Daeho ALA major holder's stake rose from 9.32% to 10.33%.10.33%
8/7GC Medical ScienceA major holder's stake rose from 12.01% to 12.96% (open-market sale).12.96%
8/7Great New wave ComingA major holder's stake rose from 72.79% to 73.71% (open-market buy).73.71%
8/7EyesvisionA major holder's stake rose from 34.46% to 35.18% (open-market buy).35.18%
8/7Playwith KoreaA major holder's stake rose from 36.72% to 37.40% (related-party change).37.40%
All 5% holders →

Buybacks 12

8/7BuybackHyundai G.f. HoldingsPlans to buy back 4,226,542 sh of treasury stock, Aug 10 to Oct 30.₩50B
8/7AmendedBuybackMcnexPlans to buy back 315,457 sh of treasury stock, Aug 10 to Nov 9.₩6B
8/7Trusti-Scream MediaSigned a ₩5B trust contract to buy back shares.₩5B
8/7TrustADforusSigned a ₩3B trust contract to buy back shares.₩3B
8/7TrustTotal Soft BankSigned a ₩2B trust contract to buy back shares.₩2B
8/7TrustNew Kids OnSigned a ₩1B trust contract to buy back shares.₩1B
8/7DisposalSK hynixPlans to dispose of 82 sh of treasury stock, Aug 8 to Sep 7.₩122.6M
8/7UJU ElectronicsShare cancellation
8/7SK SquareTreasury stock disposal
8/7SC EngineeringShare cancellation
8/7HpspTreasury stock disposal
8/7McnexTreasury stock acquisition

Share issues & bonds 21

8/7AmendedRights offeringSambu ConstructionIssuing 115,010,416 sh of new shares, equal to 1360.2% of existing shares.1360.2%
8/7AmendedCapital reductionSambu ConstructionCapital reduction of 96.3%.96.3%
8/7AmendedCapital reductionSambu ConstructionCapital reduction of 95%.95%
8/7AmendedCBBlue Industrial DevelopmentConversion price ₩4,665; if all converted, equal to 22.6% of shares outstanding.₩5B
8/7Rights offeringCuroholdingsIssuing 1,264,409 sh of new shares, equal to 20% of existing shares.₩3.4B
8/7CBIremConversion price ₩2,130; if all converted, equal to 14.6% of shares outstanding.₩2.5B
8/7Rights offeringInnogeneIssuing 600,000 sh of new shares, equal to 4.2% of existing shares.₩840M
8/7AmendedSambu ConstructionRights offering
8/7AmendedCellfie GlobalRights offering
8/7AmendedBlue Industrial DevelopmentRights offering
8/7AmendedBlue Industrial DevelopmentRights offering
8/7AmendedBlue Industrial DevelopmentRights offering
8/7AmendedBlue Industrial DevelopmentRights offering
8/7E8Rights offering
8/7Seoul Electronics & TelecomRights offering
8/7AmendedSangji ConstructionRights offering
8/7AmendedSangji ConstructionRights offering
8/7HLB TherapeuticsRights offering
8/7AmendedHLB TherapeuticsConvertible bond issue
8/7AmendedHLB TherapeuticsConvertible bond issue
8/7AmendedVECT RoboticsRights offering

M&A & spin-offs 3

8/7Shinyoung WacoalA ₩80B deal, equal to 18.7% of total assets.₩80B
8/7AmendedBitplanetTangible asset deal
8/7HLB GlobalMerger

Exchange actions 14

8/7UnisonAdministrative issue
8/7DukshinepcAdministrative issue
8/7AmendedSI ResourcesUnfaithful disclosure
8/7SeohanSpin-off / split
8/7Clean & ScienceAdministrative issue
8/7From BioTrading halt
8/7I-RoboticsExchange inquiry
8/7MakinaRocksExchange inquiry
8/7DukshinepcSpin-off / split
8/7CreoSGExchange inquiry
8/7QuratisExchange inquiry
8/7DHX CompanyExchange inquiry
8/7Chinhung InternationalInvestment caution
8/7AUKExchange inquiry